Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Factor Health MD vs NewSelf

Factor Health MD
Graded #181

Lower grade

vs+12.3
NewSelf
Graded #39

Higher grade

The verdict

NewSelf takes it — 79.8/100 to 67.5/100.

NewSelf grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Round-$100 semaglutide, $144 tirzepatide, verified and available in all 50 states.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueNewSelf +9
84
93
Dose & formulationNewSelf +11
69
80
Clinical oversightFactor Health MD +14
69
55
Labs & monitoringNewSelf +31
51
82
FulfillmentNewSelf +30
57
87
Contract termsNewSelf +30
55
85
Factor Health MD · left barNewSelf · right bar

The numbers

MetricFactor Health MDNewSelf
WeighScore67.5/10079.8/100
GradeCC+
Scorecard rank#181#39
Semaglutide$99/mo (starting dose, compounded)$100/mo
Tirzepatide$149/mo (compounded)$144/mo
CoverageCoverage not publishedAll 50 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Factor Health MD

Graded #181 · C

Strengths

  • Three-GLP-1 lineup including liraglutide — rare in DTC and useful for patients sensitive to newer molecules
  • Aggressive $99/mo starting tier with all doses included
  • Multi-product platform (GLP-1, longevity, vitamin injectables, men's health, bundles)
  • HSA/FSA accepted — uncommon for compounded GLP-1
  • St. Petersburg, FL location and phone (305-930-8817) for accountability

Where it loses points

  • 503A/503B pharmacy partner not named
  • Full states-served list not disclosed
  • No named medical director
  • FDA compounded-medication disclaimer not prominently displayed
  • Corporate legal entity not disclosed
NewSelf

Graded #39 · C+

FDAWarning letter issued to NewSelf Limited dba NewSelf in February 2026. See the FDA warning-letter database.

Strengths

  • $100 sema / $144 tirz
  • All 50 states, LegitScript-verified
  • Both molecules

Where it loses points

  • Injection-only
  • Labs/monitoring detail sparse
  • Limited brand history

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 544 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard